Zhejiang Yatai Pharmaceutical Hits Day High with 10.04% Surge

Zhejiang Yatai Pharmaceutical Co., Ltd. has experienced a significant surge in its stock price, gaining 10.04% on June 29, 2026. The stock reached an intraday high of CNY 5.37, marking a notable performance against the backdrop of the China Shanghai Composite, which only increased by 1.16% on the same day. In terms of performance metrics, Zhejiang Yatai has shown a 9.15% increase over the past week, contrasting with a decline of 2.14% in the broader market. However, the company's longer-term performance reveals mixed results, with a year-to-date decline of 26.54% compared to a modest gain of 2.65% for the Shanghai Composite. Over the past year, the stock has appreciated by 40.94%, significantly outperforming the index's 18.97% rise. Despite the recent uptick, the company faces challenges, including a low return on capital employed and negative net worth. The pharmaceutical and biotechnology sector remains competitive, and Zhejiang Yatai's market capitalization stands at CNY 2,550 million, categorizing it as a small-cap entity.